Texas-based MedCognetics received FDA 510(k) clearance for its AI-powered breast cancer screening software QmTRIAGE.
QmTRIAGE uses AI to analyze 2D full-field digital mammography screenings and flags those suggestive of abnormalities for radiologists' review.
MedCognetics' software uses datasets gathered from de-identified clinical data from UT Southwestern Medical Center in Dallas and...
